Description: Emerging Applications of ESG Methods offers ground-up insights on cutting edge applications of economic scenario generation. The course will focus on the incorporation of climate change risk in scenario modeling and investment applications of ESGs. The following topics will be covered: Approaches to climate risk modeling. Climate risk is very different than classical financial economic risk. Radical uncertainty is amenable to scenario analysis and lack of data. Building special deterministic scenarios that go beyond NGFS requirements as well as bespoke scenarios. Holistic Approach to Climate Risk Modeling. Overview of different Climate Risk Modeling Applications. Use of ESG scenarios for Strategic Asset Allocation (SAA). Liquidity risk management.

Description: This session will explore the evolving landscape of accident and health valuation, with a special focus on GAAP Long Duration Targeted Improvements. Discussion will delve into the intricacies of change brought by GAAP LDTI for calculation of both Lifetime Future Policy Benefits (LFPB) and Deferred Acquisition Costs, as well as potential downstream impacts to other activities related to general GAAP and STAT reserving such as experience analysis, model system conversion, financial planning and analysis, and statutory margin analysis. Attendees should be able to connect accounting and financial reporting concepts under GAAP LDTI to opportunities for technology modernization, improved transparency of financial analytics, and important considerations unique to Accident and Health products.

Description: With large public filers having adopted LDTI in 2023, company practices are continuing to evolve as it relates to experience monitoring, assumption unlocking, as well as both internal and external communication and disclosures related to assumptions. In this diverse session featuring representatives from both insurance companies as well as industry analysts, we'll explore how companies approach emerging experience in a given year through a case study approach. The moderator will explore various topics such as off-cycle experience monitoring, experience outliers, simplifications and approximations, and materiality considerations. Each 'what-if' scenario will start with a prompt from the moderator, discussion among the industry panelists as to how they would approach the situation within their own organization, followed by commentary from the analysts as to how they might expect companies to respond in each case. Audience participation will be encouraged to explore potential alternative approaches in an engaging, interactive session.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Good quality data is a key part of all actuarial process and financial reporting. How do you store and manage data? What are your data validation and controls? Who performs them (IT or Business)? Hear from our panel on what they do and what they deem as best practices.

Description: This session is intended to provide an update on past, current, and future studies done by the SOA GLTD Experience Committee. This includes an update on the ongoing Group LTD Incidence Survey including the nature of the study, goals, timelines, data submissions, and current status.

Description: This webcast will walk through several statistical methods for imputing race and ethnicity from U.S. datasets, highlighting their strengths and weaknesses, talking about how to use them and evaluating their accuracy, and telling you where you can get code packages as well as a free dataset to try the methods out.